C05YYZZ
Nonimaging Nuclear Medicine Probe Central Nervous System to None with None, Other Radionuclide Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | 0 Central Nervous System |
| Operation | 5 Nonimaging Nuclear Medicine Probe |
| Body Part | Y Central Nervous System |
| Approach | Y Other Radionuclide |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for the study of distribution and fate of certain substances by the detection of radioactive emissions; or, alternatively, measurement of absorption of radioactive emissions from an external source
Procedure Overview
A nonimaging nuclear medicine probe study of the central nervous system uses a radioactive tracer to track how a substance moves or distributes within the body, or measures radiation reaching an external detector, without generating a picture. In neurological practice this most often takes the form of a cerebrospinal fluid (CSF) flow study, sometimes called a cisternogram or shunt patency study, in which a tracer is introduced into the CSF space and a detector or counter records how the fluid moves over time.
These studies help determine whether a ventricular shunt used to treat hydrocephalus is functioning properly, whether CSF is leaking outside its normal pathways, or whether cerebrospinal fluid circulation is obstructed. Rather than producing anatomical images for a radiologist to inspect visually, the procedure generates numeric or graphical data, such as counts over time, that quantify flow or clearance.
Anatomy & Axis Detail
Central Nervous System
When the target is described simply as the central nervous system rather than a discrete structure, the nonimaging probe is used to sample radiotracer activity from the brain and spinal cord collectively, typically in protocols assessing cerebrospinal fluid dynamics or shunt function that are not confined to a single anatomic site. This general body part value is selected when the study protocol does not isolate the brain alone, such as when counts are taken along the neuraxis to trace flow. Documentation should specify the reason probe measurement was chosen over full imaging, since the two convey different clinical information. The distinction between a discrete brain probe and this broader central nervous system designation depends entirely on how the ordering physician defined the target of the study.
Radionuclide: Other Radionuclide
Other Radionuclide is used when a nuclear medicine study employs a radioactive tracer that does not correspond to one of the specifically named isotope values in this axis, such as an uncommon or newer radiopharmaceutical. It functions as a catch-all so the procedure can still be coded precisely by section and root operation even when the exact tracer lacks its own dedicated code value.
Coding & Documentation
This code applies when the documentation makes clear that no image was produced and that the purpose was quantitative tracking or a probe-based measurement, such as confirming tracer movement through or blockage of a shunt system. The tracer used and the specific measurement obtained (such as time-activity data) should be documented to support code selection.
The most common coding error is applying this root operation to a study that actually included imaging, since many CSF studies are performed alongside delayed gamma camera images; if any imaging occurred, a Tomographic or Planar imaging code may be more appropriate for that portion of the exam. Coders should read the full report carefully to determine whether images were generated at any point in the study.
Commonly Confused With
This family is distinguished from both Tomographic and Planar Nuclear Medicine Imaging of the CNS by the absence of any generated image; those families exist specifically to produce a picture, while this one produces a measurement or tracked value. It can be confused with shunt series studies performed under plain radiography, but those use x-ray rather than radioactive tracer detection and belong to a different section entirely.
